Pricing Log in Create free account

Lexaria Bioscience Corp. (LEXX) vs Alaunos Therapeutics, Inc. (TCRT)

Lexaria Bioscience Corp. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Lexaria Bioscience Corp. and Alaunos Therapeutics, Inc. are of similar size ($6.4M and $6.3M). Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 9.08% against −17.7%. Across the 13 metrics below, Lexaria Bioscience Corp. leads on 8 and Alaunos Therapeutics, Inc. on 5.

Valuation

Metric LEXX TCRT Biotechnology median
P/E n/m n/m 8.50
P/S 8.91 456.87 9.71
P/B 1.11 9.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2.36 1,552.30 9.21
Earnings yield (174.57%) (72.62%) (33.15%)
Free cash flow yield (155.80%) (20.65%) (25.50%)

Profitability

Metric LEXX TCRT Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (162.60%) (185.95%) (56.36%)
Return on assets (134.20%) (128.30%) (48.04%)
Return on invested capital (662.56%) (480.35%) 0.00%

Growth

Metric LEXX TCRT Biotechnology median
Revenue growth (TTM) 9.08% (17.65%) 6.02%
EPS growth (last fiscal year) (40.43%) 24.66% 30.26%
Revenue growth, 5-year CAGR 17.53% (49.08%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LEXX TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.60 0.77 4.72
Net debt to EBITDA 0.17 0.33 0.96

Dividend

Metric LEXX TCRT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LEXX TCRT Biotechnology median
Market cap 6.30m 6.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack